Results from the Phase III VEGA-3 trial show that a significantly higher number of patients with presbyopia who received ...

The transaction, finalized following regulatory clearance, includes two FDA-approved rare tumor therapies: Ogsiveo for ...

Results from the Phase III Vivacity-MG3 trial show that Imaavy provides more consistent disease control than other approved ...

Jeff Liter, CEO of Luminary, discusses his company’s approach to CAR-T therapies and why the developing Saudi market has ...

Due to popularity of the medications, GLP-1s were in short supply up until recently. Obesity is a common issue among ...

Former Philadelphia Eagles quarterback Rodney Peete joined Sumitomo Pharma America’s Time to Go campaign. 1 The promotional ...